name:-0.10661196708679
name:-0.49797201156616
name:-0.045720100402832
Xintela AB Patent Filings

Xintela AB

Patent Applications and Registrations

Patent applications and USPTO patent grants for Xintela AB.The latest application filed is for "detection and treatment of malignant tumours in the cns".

Company Profile
10.17.22
  • Xintela AB - Lund SE
  • Xintela AB - Bjarred N/A SE
  • Xintela AB -
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks
Patent Activity
PatentDate
Detection and Treatment of Malignant Tumours in the CNS
App 20210316005 - Lundgren kerlund; Evy ;   et al.
2021-10-14
Detection and treatment of malignant tumours in the CNS
Grant 10,994,022 - Lundgren-.ANG.kerlund , et al. May 4, 2
2021-05-04
Quality Assurance Of Chondrocytes
App 20200377858 - Lundgren kerlund; Evy ;   et al.
2020-12-03
Quality assurance of chondrocytes
Grant 10,781,424 - Lundgren .ANG.kerlund , et al. Sept
2020-09-22
Prevention and treatment of bone and cartilage damage or disease
App 20200038449 - Lundgren kerlund; Evy ;   et al.
2020-02-06
Marker for Neural Stem Cells
App 20190369093 - LUNDGREN KERLUND; Evy ;   et al.
2019-12-05
Quality Assurance of Chondrocytes
App 20190300855 - Lundgren kerlund; Evy ;   et al.
2019-10-03
Monoclonal antibody capable of binding integrin alpha 10 beta 1
Grant 10,087,253 - Lundgren-Akerlund October 2, 2
2018-10-02
Integrin heterodimer and a subunit thereof
Grant 10,081,666 - Lundgren-Akerlund September 25, 2
2018-09-25
Detection and treatment of malignant tumours in the CNS
App 20180236094 - Lundgren- kerlund; Evy ;   et al.
2018-08-23
Integrin Heterodimer And A Subunit Thereof
App 20180079795 - LUNDGREN-AKERLUND; Evy
2018-03-22
Integrin Heterodimer And A Subunit Thereof
App 20170121386 - LUNDGREN-AKERLUND; Evy
2017-05-04
Monoclonal Antibody Capable Of Binding Integrin Alpha 10 Beta 1
App 20160319023 - Lundgren-Akerlund; Evy
2016-11-03
Monoclonal antibody capable of binding integrin alpha 10 beta 1
Grant 9,365,649 - Lundgren- kerlund June 14, 2
2016-06-14
Integrin heterodimer and a subunit thereof
Grant 8,895,253 - Lundgren-Akerlund November 25, 2
2014-11-25
Monoclonal Antibody Capable Of Binding Integrin Alpha 10 Beta 1
App 20140099716 - Lundgren-Akerlund; Evy
2014-04-10
Monoclonal antibody capable of binding integrin alpha 10 beta 1
Grant 8,563,255 - Lundgren-Akerlund October 22, 2
2013-10-22
Integrin Heterodimer And A Subunit Thereof
App 20130137118 - LUNDGREN-AKERLUND; Evy
2013-05-30
Integrin Heterodimer And A Subunit Thereof
App 20120136141 - Lundgren-Akerlund; Evy
2012-05-31
Monoclonal Antibody Capable of Binding Integrin Alpha 10 Beta 1
App 20120034625 - Lundgren-Akerlund; Evy
2012-02-09
Marker for stem cells and its use
Grant 8,105,791 - Lundgren-.ANG.kerlund January 31, 2
2012-01-31
Antibody to an integrin heterodimer and/or a subunit thereof
Grant 8,048,991 - Lundgren-.ANG.kerlund November 1, 2
2011-11-01
Monoclonal antibody capable of binding integrin alpha 10 beta 1
Grant 8,012,696 - Lundgren-.ANG.kerlund September 6, 2
2011-09-06
Marker For Stem Cells And Its Use
App 20110033923 - Lundgren-Akerlund; Evy
2011-02-10
Marker for stem cells and its use
Grant 7,749,710 - Lundgren-.ANG.kerlund July 6, 2
2010-07-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed